[
    [
        {
            "time": "2020-05-14",
            "original_text": "恒瑞医药获临床试验通知书",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "临床试验",
                    "通知书"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "恒瑞医药获临床试验通知书",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-05-14",
            "original_text": "陆股通净卖出13.25亿元（附名单）",
            "features": {
                "keywords": [
                    "陆股通",
                    "净卖出",
                    "资金流出"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "陆股通净卖出13.25亿元（附名单）",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-05-14",
            "original_text": "高瓴创新药赛道布局详解",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "创新药",
                    "投资布局"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "高瓴创新药赛道布局详解",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-05-14",
            "original_text": "注射剂一致性评价来了 6000亿元市场生死时速上演",
            "features": {
                "keywords": [
                    "注射剂",
                    "一致性评价",
                    "市场变化"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "注射剂一致性评价来了 6000亿元市场生死时速上演",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-05-14",
            "original_text": "科技板块蠢蠢欲动 防御思维依然不休",
            "features": {
                "keywords": [
                    "科技板块",
                    "蠢蠢欲动",
                    "防御思维"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "科技板块蠢蠢欲动 防御思维依然不休",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-05-14",
            "original_text": "A股最大药企受贿案牵出药品“带金销售”灰色利益链",
            "features": {
                "keywords": [
                    "受贿案",
                    "带金销售",
                    "灰色利益链"
                ],
                "sentiment_score": -0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "A股最大药企受贿案牵出药品“带金销售”灰色利益链",
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-05-14",
            "original_text": "注射剂‘降价潮’将开启加速模式",
            "features": {
                "keywords": [
                    "注射剂",
                    "降价潮",
                    "加速模式"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "注射剂‘降价潮’将开启加速模式",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-05-14",
            "original_text": "注射剂一致性评价：恒瑞、齐鲁、正大天晴领跑",
            "features": {
                "keywords": [
                    "注射剂",
                    "一致性评价",
                    "恒瑞",
                    "齐鲁",
                    "正大天晴"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "注射剂一致性评价：恒瑞、齐鲁、正大天晴领跑",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-05-14",
            "original_text": "司太立：子公司申报的碘帕醇注射液已获审批通过",
            "features": {
                "keywords": [
                    "司太立",
                    "碘帕醇注射液",
                    "审批通过"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "司太立：子公司申报的碘帕醇注射液已获审批通过",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-05-14",
            "original_text": "恐慌，再度归来！沪指急跌0.96%收2870",
            "features": {
                "keywords": [
                    "恐慌",
                    "沪指急跌",
                    "市场情绪"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "恐慌，再度归来！沪指急跌0.96%收2870",
                "Correlation": 6,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 10,
                "Time_Proximity": 10,
                "Headline_Structure": 10,
                "Source_Recency": 10
            }
        }
    ]
]